Skip Navigation

Journal of Tropical Pediatrics 2001 47(6):345-349; doi:10.1093/tropej/47.6.345
© 2001 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jeffery, B. S.
Right arrow Articles by Erasmus, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeffery, B. S.
Right arrow Articles by Erasmus, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Determination of the Effectiveness of Inactivation of Human Immunodeficiency Virus by Pretoria Pasteurization

B. S. Jeffery1, L. Webber2, K. R. Mokhondo1 and D. Erasmus2

1 Department of Obstetrics and Gynecology, Kalafong Hospital and University of Pretoria, MRC Maternal and Infant Health Care Strategies Research Unit, South Africa 2 Department of Medical Virology, University of Pretoria, South Africa

The risk of transmission of the human immunodeficiency virus (HIV) via breastfeeding is between 10 and 17 per cent. In resource-poor countries most HIV-infected women cannot afford to formula feed their infants and formula feeding is not desirable in areas of high infant mortality because of loss of the immunological benefits of breastmilk. A method has been devised by which HIV-infected women may express and pasteurize their breastmilk in a domestic setting using inexpensive apparatus and a simple technique. The method, Pretoria Pasteurization has been shown to be reliable under a wide range of conditions and maintains milk between 56° and 62.5° C for between 12 and 15 min. This study was devised to determine whether Pretoria Pasteurization effectively inactivates HIV in human milk. Samples of expressed breastmilk were obtained from a group of HIV-infected lactating women and a group of HIV-negative women. The samples of milk from the HIV-negative women were inoculated with high titres of cell-associated and cell-free HIV. Each sample was divided into a control portion and a study portion. The study portion underwent Pretoria Pasteurization. Control and pasteurized samples were inoculated into lymphocyte co-culture for a period of 35 days. All co-cultures were sampled weekly and analysed by serological and molecular methods for p24 antigen, cell-free HIV RNA and integrated DNA. Viral RNA was detected in the milk of 80 per cent amongst the known HIV-positive women. The mean serum viral load in the group of HIV positive women was 50 728 copies/ml and the mean milk viral load was 422 000 copies/ml. Evidence of viral replication was shown in 11 of the control specimens. There was no evidence of viral replication in any of the study specimens which had undergone Pretoria Pasteurization. It was concluded that Pretoria Pasteurization effectively inactivates HIV in human milk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Hum LactHome page
K. A. Israel-Ballard, M. C. Maternowska, B. F. Abrams, P. Morrison, L. Chitibura, T. Chipato, Z. M. Chirenje, N. S. Padian, and C. J. Chantry
Acceptability of Heat Treating Breast Milk to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus in Zimbabwe: A Qualitative Study
J Hum Lact, February 1, 2006; 22(1): 48 - 60.
[Abstract] [PDF]


Home page
J Hum LactHome page
S. U. Hartmann, B. Wigdahl, E. B. Neely, C. M. Berlin, C.-L. Schengrund, H.-M. Lin, and M. K. Howett
Biochemical Analysis of Human Milk Treated With Sodium Dodecyl Sulfate, an Alkyl Sulfate Microbicide That Inactivates Human Immunodeficiency Virus Type 1
J Hum Lact, February 1, 2006; 22(1): 61 - 74.
[Abstract] [PDF]


Home page
J Hum LactHome page
S. U. Hartmann, C. M. Berlin, and M. K. Howett
Alternative Modified Infant-Feeding Practices to Prevent Postnatal Transmission of Human Immunodeficiency Virus Type 1 Through Breast Milk: Past, Present, and Future
J Hum Lact, February 1, 2006; 22(1): 75 - 88.
[Abstract] [PDF]


Home page
PediatricsHome page
J. S. Read and Committee on Pediatric AIDS
Human Milk, Breastfeeding, and Transmission of Human Immunodeficiency Virus Type 1 in the United States
Pediatrics, November 1, 2003; 112(5): 1196 - 1205.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.